Načítá se...
Use of antibodies and immunoconjugates for the therapy of more accessible cancers
There are currently 6 unconjugated antibodies and 3 immunoconjugates approved for use in the Unites States in a variety of cancers, with a considerable number of new agents in clinical testing and preclinical development. Unconjugated antibodies alone can be effective, but more often, antibodies nee...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2575231/ https://ncbi.nlm.nih.gov/pubmed/18508155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2008.04.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|